latest update:
[TrialBase DB]

trial summary · NCT07812233

Heart Rate Variability Biofeedback for Anxiety in Autistic Youth

Trial record from the TrialBase DB dataset, status RECRUITING, condition Autism Spectrum Disorder, sponsored by Massachusetts General Hospital. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07812233phase PHASE2enrollment 50start 2026-10-26

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Heart rate variability biofeedback (HRVB) is a breathing-based intervention that reduces anxiety in a range of populations. Second-generation wearable HRVB devices not only deliver scheduled biofeedback practice sessions but also allow patients to practice HRVB in-the-moment when it is needed most. This study is testing the acceptability, feasibility, and preliminary efficacy of second-generation, ambulatory HRVB for the treatment of anxiety in autistic youth.

Source record: https://clinicaltrials.gov/study/NCT07812233

Facts

registry idNCT07812233
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE2
study typeINTERVENTIONAL
lead conditionAutism Spectrum Disorder
sponsorMassachusetts General Hospital
sponsor classOTHER
enrollment50
start date2026-10-26
primary completion2029-05
completion2029-05
results postednot reported

Conditions

  • Autism Spectrum Disorder
  • Anxiety

Interventions

  • Lief Smart Patch

Countries

  • United States

Intervention types: DEVICE

Work with this record